VistaGen Therapeutics, Inc. (NASDAQ:VTGN) has a beta value of 0.49 and has seen 970,530 shares traded in the last trading session. The company, currently valued at $60.39 Million, closed the last trade at $0.82 per share which meant it gained $0.06 on the day or 7.3% during that session. The VTGN stock price is -81.71% off its 52-week high price of $1.49 and 64.63% above the 52-week low of $0.29. If we look at the company’s 10-day average daily trading volume, we find that it stood at 692.11 Million shares traded. The 3-month trading volume is 2.15 Million shares.

The consensus among analysts is that VistaGen Therapeutics, Inc. (VTGN) is an Overweight stock at the moment, with a recommendation rating of 2.3. None of the analysts rate the stock as a Sell, while none rate it as Overweight. 1 out of 3 have rated it as a Hold, with 2 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is -$0.02.

VistaGen Therapeutics, Inc. (NASDAQ:VTGN) trade information

Sporting 7.3% in the green today, the stock has traded in the green over the last five days, with the highest price hit on Wednesday, Oct 14 when the VTGN stock price touched $0.85 or saw a rise of 3.99%. Year-to-date, VistaGen Therapeutics, Inc. shares have moved 18.33%, while the 5-day performance has seen it change 9.54%. Over the past 30 days, the shares of VistaGen Therapeutics, Inc. (NASDAQ:VTGN) have changed 23.99%. Short interest in the company has seen 2.51 Million shares shorted with days to cover at 1.17.

Wall Street analysts have a consensus price target for the stock at $4.5, which means that the shares’ value could jump 448.78% from current levels. The projected low price target is $3 while the price target rests at a high of $6. In that case, then, we find that the current price level is +631.71% off the targeted high while a plunge would see the stock lose 265.85% from current levels.

VistaGen Therapeutics, Inc. (VTGN) estimates and forecasts

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was +45.6% over the past 5 years. Earnings growth for 2020 is a modest +44.2%.